You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 90 No. 4, OCTOBER 1952 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

PORPHYRIA CUTANEA TARDA

Investigation of a Case, Including Isolation of Some Hitherto Undescribed Porphyrins

ALASTAIR G. MACGREGOR, M.D., M.R.C.P.; R. E. H. NICHOLAS, Ph.D., A.R.I.C.; C. RIMINGTON, Ph.D., D.Sc.

AMA Arch Intern Med. 1952;90(4):483-504.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

WALDENSTRÖM1 has divided the porphyrias into the following groups:

  1. Porphyria congenita, a familial disease, probably recessive in character, present at birth and characterized by sensitivity to light, pigmented bones and teeth, and greatly increased coproporphyrin and uroporphyrin excretion, mainly of Series I.
  2. Porphyria cutanea tarda, a disease in which the porphyrinuria and sensitivity to light develop later in life and a sclerodermic tendency is noticeable. The occurrence of colic and the occasional excretion in the urine of uroporphyrin suggest a relationship with the group next to be described. Severe nervous symptoms have not yet been reported.2
  3. Porphyria acuta, a familial disease, dominant in character, accompanied with the excretion of coproporphyrin and uroporphyrin mainly of Series III. The following clinical forms have been recognized: (a) Latent porphyria in which there is increased uroporphyrin excretion without any clinical manifestations of porphyria; such patients as have been encountered have always been
. . . [Full Text PDF of this Article]


Author Affiliations

SHEFFIELD, ENGLAND; LONDON, ENGLAND

From the Department of Pharmacology and Therapeutics, University of Sheffield, Sheffield, England, and the Department of Chemical Pathology, University College Hospital Medical School, London, England.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1952 American Medical Association. All Rights Reserved.